A Structured Exercise Program for Patients with Advanced Non-small Cell Lung Cancer

被引:139
|
作者
Temel, Jennifer S. [1 ]
Greer, Joseph A. [1 ]
Goldberg, Sarah [1 ]
Vogel, Paula Downes [1 ]
Sullivan, Michael [1 ]
Pirl, William F. [1 ]
Lynch, Thomas J. [1 ]
Christiani, David C. [1 ]
Smith, Matthew R. [1 ]
机构
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
关键词
Non-small cell lung cancer; Exercise; Supportive care; QUALITY-OF-LIFE; HIGH-DOSE CHEMOTHERAPY; PHYSICAL-ACTIVITY; BREAST-CANCER; FUNCTIONAL ASSESSMENT; MEGESTROL-ACETATE; AEROBIC EXERCISE; OUTPATIENT REHABILITATION; PULMONARY REHABILITATION; RESISTANCE EXERCISE;
D O I
10.1097/JTO.0b013e31819d18e5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: Exercise improves functional outcome and symptoms for certain cancer populations, but the feasibility, efficacy, and safety of structured exercise in patients with lung cancer is unknown. In this Study, we examined the feasibility of a hospital-based exercise program for patients with advanced non-small cell lung cancer. Methods: This study included patients with newly diagnosed advanced stage non-small cell lung cancer and Eastern Cooperative Oncology Group performance status 0-1. A physical therapist facilitated twice-weekly sessions of aerobic exercise and weight training over an 8-week period. The primary end point was feasibility of the intervention, defined as adherence to the exercise program. Secondary endpoints included functional capacity, measured by the 6-minute walk test and Muscle strength, as well as quality Of life, lung cancer symptoms and fatigue, measured by the Functional Assessment of Cancer Therapy-lung and Functional Assessment of Cancer Therapy-fatigue scales. Results: Between October 2004 and August 2007, 25 patients enrolled in the study. All participants received anticancer therapy during the Study period. Twenty patients (80%) underwent the baseline physical therapy evaluation. Eleven patients (44%) completed all 16 sessions. An additional 6 patients attended at least 6 sessions (range, 6-15), and 2 patients only attended one session. Study completers experienced a significant reduction in lung cancer symptoms and no deterioration in their 6-minute walk test or muscle strength. Conclusions: Although the majority of participants attempted the exercise program, less than half were able to complete the intervention. Those who completed the program experienced an improvement in their lung cancer symptoms. Community-based or briefer exercise interventions may be more feasible in this population.
引用
收藏
页码:595 / 601
页数:7
相关论文
共 50 条
  • [31] Treatment of older patients with advanced non-small cell lung cancer: A challenge
    Decoster, Lore
    Schallier, Denis
    JOURNAL OF GERIATRIC ONCOLOGY, 2019, 10 (04) : 528 - 533
  • [32] Gemcitabine plus carboplatin in patients with advanced non-small cell lung cancer
    Park, SH
    Jeong, SH
    Kyung, SY
    Lim, YH
    An, CH
    Lee, SP
    Park, JW
    Bang, SM
    Cho, EK
    Shin, DB
    Lee, JH
    MEDICAL ONCOLOGY, 2005, 22 (04) : 359 - 366
  • [33] Immunotherapy Beyond Progression for Patients with Advanced Non-Small Cell Lung Cancer
    Ge, X.
    Zhang, Z.
    Yan, X.
    Zhang, F.
    Yuan, F.
    Han, X.
    Huang, Z.
    Ma, J.
    Wang, L.
    Tao, H.
    Li, X.
    Zhang, S.
    Zhi, X.
    Hu, Y.
    Wang, J.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S641 - S642
  • [34] Prolonged infusion of etoposide in patients with advanced non-small cell lung cancer
    Robert, F
    Molthrop, DC
    Miller, AA
    Lee, BC
    Chen, S
    Wheeler, RH
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1996, 19 (05): : 483 - 486
  • [35] Management of Elderly Patients with Advanced Non-Small Cell Lung Cancer in Turkey
    Yildirim, Yesim
    Ozyilkan, Ozgur
    Calikusu, Zuleyha
    Akcali, Zafer
    Akcay, Yesim
    Demirhan, Beyhan
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2009, 10 (04) : 699 - 700
  • [36] Treatment Toxicity in Elderly Patients With Advanced Non-Small Cell Lung Cancer
    Kale, Minal S.
    Mhango, Grace
    Gomez, Jorge E.
    Sigel, Keith
    Smith, Cardinale B.
    Bonomi, Marcelo
    Wisnivesky, Juan P.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2017, 40 (05): : 470 - 476
  • [37] Prognostic Factors in Elderly Patients with Advanced Non-Small Cell Lung Cancer Treated with Chemotherapy
    Li, Jian
    Chen, Ping
    Dai, Chun-Hua
    Li, Xiao-Qin
    Bao, Quan-Lei
    ONCOLOGY, 2009, 76 (05) : 355 - 362
  • [38] Pharmacokinetics of Cemiplimab in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
    Papachristos, A.
    Masinde, S.
    Davis, J. D.
    Gullo, G.
    Rietschel, P.
    Paccaly, A.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S308 - S309
  • [39] Management of patients with advanced non-small cell lung cancer: role of gefitinib
    Velcheti, Vamsidhar
    Morgensztern, Daniel
    Govindan, Ramaswamy
    BIOLOGICS-TARGETS & THERAPY, 2010, 4 : 83 - 90
  • [40] Circulating DNA is a Useful Prognostic Factor in Patients with Advanced Non-small Cell Lung Cancer
    Sirera, Rafael
    Bremnes, Roy M.
    Cabrera, Andrea
    Jantus-Lewintre, Eloisa
    Sanmartin, Elena
    Blasco, Ana
    del Pozo, Nieves
    Rosell, Rafael
    Guijarro, Ricardo
    Galbis, Jose
    Javier Sanchez, Jose
    Camps, Carlos
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (02) : 286 - 290